Navigation Links
World-Renowned Gastroenterologist Jean-Frédéric Colombel, MD, Joins the Icahn School of Medicine at Mount Sinai
Date:7/22/2013

New York, NY (PRWEB) July 22, 2013

The Mount Sinai Medical Center has named Jean-Frédéric Colombel, MD, as the Director of The Leona M. and Harry B. Helmsley Charitable Trust Inflammatory Bowel Disease Center, which is scheduled to open in 2014. Dr. Colombel also recently joined the faculty of the Icahn School of Medicine at Mount Sinai as Professor of Medicine, Gastroenterology.

“Dr. Colombel is an internationally-renowned clinician and researcher in inflammatory bowel disease and gastroenterology,” said Bruce Sands, MD, Professor of Medicine, Gastroenterology and Chief of the Henry D. Janowitz Division of Gastroenterology at the Icahn School of Medicine. “He will lead a team of clinicians and researchers in a fully integrated, state-of-the-art facility to provide comprehensive IBD diagnostics and treatments for adults and children and to advance translational IBD research.”

Dr. Colombel is best known for his participation in the identification of NOD2 as a susceptibility gene for Crohn’s disease, and the identification of a new subtype of Escherichia coli associated with Crohn’s disease, as well as the development of the Anti-Saccharomyces Cerevisiae Antibody (ASCA) test, which remains the most sensitive and specific marker for Crohn’s disease. He has authored or coauthored more than 500 peer-reviewed articles, books, and book chapters on IBD.

Most recently, he was Professor of Hepatogastroenterology at Centre Hospitalier Universitaire de Lille in Lille, France, and President of the European Crohn’s and Colitis Organization.

The Center will offer patients a collaborative team of experts in gastroenterology, clinical immunology, nutrition, pathology, psychology, radiology, colorectal and laparoscopic surgery, and genetics and genomics. Its Young Adult IBD Transitional Program will assure patients a seamless transition from pediatric to adult gastroenterologists.

The Center’s scientists will conduct genomic, proteomic, metabolomic, and microbiomic research to create disease models that would identify biomarkers for disease type and pathways, with the ultimate goal of developing approaches to disrupt the pathogenesis of the disease and to treat at-risk patients before IBD develops. Mount Sinai’s IBD Registry and Biobank, which analyzes complex data at every stage of a patient’s life, will collaborate to drive this research and expand Mount Sinai’s clinical trial capabilities.

About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and the Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School of Medicine is one of the leading medical schools in the United States, and is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Mount Sinai is one of 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and by U.S. News & World Report and whose hospital is on the U.S. News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.

For more information, visit http://www.mountsinai.org.

Find Mount Sinai on:    Facebook http://www.facebook.com/mountsinainyc
Twitter @mountsinainyc
YouTube: http://www.youtube.com/mountsinainy
# # #

Read the full story at http://www.prweb.com/releases/2013/7/prweb10950720.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. HeartView Global Foundation honors World-Renowned Cardiologist, Asher Kimchi and Philanthropist Diane Brinson
2. Chopra Center Launches Online Workshop “Manifesting: Living the Life of Your Dreams” – Featuring World-Renowned Teacher and Best-Selling Author Dr. Jean Houston
3. IU gastroenterologist develops practice guidelines for most prevalent liver disease
4. AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists
5. Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend
6. IU Simon Cancer Center joins WellPoint in developing health care solutions
7. ACP joins Million Hearts to help save lives from preventable heart attacks and strokes
8. Gum disease joins hot flashes and PMS associated with womens hormones
9. Advertising Industry Veteran Pat McCrossan Joins Mangos
10. Rush joins elite group of institutions with accredited research programs
11. American Academy of Family Physicians joins AmericanEHR Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... The Margarian Law Firm has filed a class ... ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ... Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is made ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to ... shoes,” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To ... Kickstarter on Monday, July 21st. , The kit uses colorful, engaging and educational ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... torn anterior cruciate ligament (ACL) offer patients improved quality of life five years ... for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The study followed ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... in which their iMedSecure™ comes included with each system installation. RMT’s iMedHD2™ ... to remote participants for real-time collaboration and immediate decision-making requirements. While never ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... 2017  New York City-based market research firm Kalorama Information ... aware of.  From new products to new costs, to the ... recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment Arriving ... the impact the growing population and, to a more extreme ...
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
Breaking Medicine Technology: